IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 250 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $449 | -85.8% | 98,663 | -78.1% | 0.00% | -84.6% |
| Q2 2023 | $3,167 | +95.4% | 449,900 | +77.3% | 0.03% | +8.3% |
| Q4 2022 | $1,621 | -99.8% | 253,733 | +260.5% | 0.02% | +166.7% |
| Q3 2022 | $674,000 | -38.8% | 70,379 | -29.5% | 0.01% | -35.7% |
| Q2 2022 | $1,102,000 | -52.2% | 99,779 | -27.9% | 0.01% | -51.7% |
| Q1 2022 | $2,304,000 | +681.0% | 138,355 | +793.8% | 0.03% | +866.7% |
| Q4 2021 | $295,000 | -59.8% | 15,479 | -48.0% | 0.00% | -70.0% |
| Q3 2021 | $734,000 | -46.4% | 29,754 | -43.5% | 0.01% | -33.3% |
| Q2 2021 | $1,370,000 | -35.3% | 52,652 | +15.3% | 0.02% | -28.6% |
| Q4 2020 | $2,119,000 | +323.8% | 45,671 | +200.9% | 0.02% | +110.0% |
| Q3 2020 | $500,000 | -79.0% | 15,176 | -82.5% | 0.01% | -83.9% |
| Q2 2020 | $2,386,000 | – | 86,920 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MHR Fund Management | 11,997,103 | $84,459,605 | 11.88% |
| MPM BioImpact LLC | 2,950,118 | $20,768,831 | 4.18% |
| Perceptive Advisors | 14,036,410 | $98,816,326 | 2.86% |
| Velan Capital Investment Management LP | 240,000 | $1,689,600 | 1.57% |
| Parametrica Management Ltd | 96,500 | $679,360 | 1.31% |
| Boxer Capital, LLC | 3,705,133 | $26,084 | 1.21% |
| Soleus Capital Management, L.P. | 1,239,777 | $8,728,030 | 0.97% |
| Opaleye Management Inc. | 421,000 | $2,963,840 | 0.71% |
| 683 Capital Management, LLC | 1,400,000 | $9,856,000 | 0.71% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,758,759 | $12,381,665 | 0.70% |